Studies have suggested that ZAP70 is a potential therapeutic target in the tumor microenvironment (TME) and may influence the prognosis of prostate cancer and bladder cancer (Sun et al., 2021; Kang et al., 2021). This evidence concerns the gene ZAP70 and neoplasm.